The Lancet Diabetes & EndocrinologyVolume 9, Issue 9, September 2021, Pages 550-551CommentDapagliflozin in patients with COVID-19: truth or dareAuthor links open overlay panelXavier Rossello a b c d, Francisca Caimari eShow moreShareCitehttps://doi.org/10.1016/S2213-8587(21)00206-0Get rights and contentPrevious article in issueNext article in issueRecommended articlesCited by (0)View Abstract© 2021 Elsevier Ltd. All rights reserved.